LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

Home・Aandelen Lijst・Agios Pharmaceuticals Inc

Agios Pharmaceuticals Inc

Gesloten

SectorGezondheidszorg

29.42 -1.97

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

29.1

Max

29.99

Belangrijke statistieken
By Trading Economics
Inkomsten	-4.6M -108M
Verkoop	7.1M 20M
K/W Sectorgemiddelde	3.836 57.05
EPS	-1.85
Winstmarge	-541.088
Werknemers	539
EBITDA	-18M -120M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+32.45% upside

Dividenden
By Dow Jones
Volgende Winsten	30 apr 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	76M 1.6B
Vorige openingsprijs	31.39
Vorige sluitingsprijs	29.42

Nieuwssentiment

By Acuity

50%

158 / 349 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Strong Bearish Evidence

28.04 / 30.06 Steun & Weerstand

Agios Pharmaceuticals Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

19 nov 2025, 15:05 UTC

Winsten

Acquisities, Fusies, Overnames

These Stocks Are Moving the Most Today: Nvidia, Lowe's, Target, Semrush, MP Materials, Plug Power, Dycom, and More -- Barrons.com

Peer Vergelijking

Prijswijziging

Agios Pharmaceuticals Inc Prognose

Koersdoel

By TipRanks

32.45% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 39.67 USD 32.45%

Hoogste 65 USD

Laagste 25 USD

Gebaseerd op 7 Wall Street-analisten die 12-maands prijsdoelen bieden voor Agios Pharmaceuticals Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

7 ratings

Buy

Hold

Sell

Gebaseerd op 7 analisten die aandelenratings hebben gegeven aan Agios Pharmaceuticals Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

28.04 / 30.06Steun & Weerstand

Recent bearish events outweigh bullish events.

All events are bearish.

The bullish and bearish events are balanced.

Sentiment

By Acuity

158 / 349 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Agios Pharmaceuticals Inc

Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias. The company develops AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias; and AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria. Its preclinical product is siRNA for the treatment of polycythemia vera, a rare blood disorder. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.